Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (?10%) well-differentiated endocrine carcinoma staging.

Source:http://linkedlifedata.com/resource/pubmed/id/21193541

Download in:

View as

General Info

PMID
21193541